Atrial fibrillation is a supraventricular tachycardia impacting the heart's atria, resulting in an elevated heart rate and erratic cardiac activity. This arrhythmia stands as the most prevalent disease worldwide, afflicting over 33 million individuals, with a projected increase due to population aging. Among the array of treatments available for atrial fibrillation, cardiac ablation of specific triggering structures, such as the pulmonary veins, has emerged as a promising approach. This project, conducted in collaboration with Boston Scientific Inc., a leading medical device company, afforded us the opportunity to observe the POLARx Cryoablation System in action within an Italian hospital. The primary objective is the development of an algorithm proficient in analyzing procedural data derived from POLARx ablation procedures, in order to provide a quantitative assessment of hospital performance when implementing this system, ensuring continued support for medical practitioners.